These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. McCarthy JS; Rückle T; Djeriou E; Cantalloube C; Ter-Minassian D; Baker M; O'Rourke P; Griffin P; Marquart L; Hooft van Huijsduijnen R; Möhrle JJ Malar J; 2016 Sep; 15(1):469. PubMed ID: 27624471 [TBL] [Abstract][Full Text] [Related]
9. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study. McCarthy JS; Yalkinoglu Ö; Odedra A; Webster R; Oeuvray C; Tappert A; Bezuidenhout D; Giddins MJ; Dhingra SK; Fidock DA; Marquart L; Webb L; Yin X; Khandelwal A; Bagchus WM Lancet Infect Dis; 2021 Dec; 21(12):1713-1724. PubMed ID: 34715032 [TBL] [Abstract][Full Text] [Related]
10. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967 [TBL] [Abstract][Full Text] [Related]
12. The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus. Kawai S; Kano S; Chang C; Suzuki M Am J Trop Med Hyg; 1996 Aug; 55(2):223-9. PubMed ID: 8780465 [TBL] [Abstract][Full Text] [Related]
13. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Ringwald P; Bickii J; Basco L Lancet; 1996 Jan; 347(8993):24-8. PubMed ID: 8531545 [TBL] [Abstract][Full Text] [Related]
14. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related]
16. DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Collins KA; Rückle T; Elliott S; Marquart L; Ballard E; Chalon S; Griffin P; Möhrle JJ; McCarthy JS Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30858218 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Bayesian hierarchical pharmacokinetic-pharmacodynamic model for predicting parasitological outcomes in Phase 2 studies of new antimalarial drugs. Tully MK; Dini S; Flegg JA; McCarthy JS; Price DJ; Simpson JA Antimicrob Agents Chemother; 2024 Sep; 68(9):e0086324. PubMed ID: 39136464 [TBL] [Abstract][Full Text] [Related]
18. Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor. Rottmann M; Jonat B; Gumpp C; Dhingra SK; Giddins MJ; Yin X; Badolo L; Greco B; Fidock DA; Oeuvray C; Spangenberg T Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041711 [TBL] [Abstract][Full Text] [Related]
19. Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study. Barber BE; Fernandez M; Patel HB; Barcelo C; Woolley SD; Patel H; Llewellyn S; Abd-Rahman AN; Sharma S; Jain M; Ghoghari A; Di Resta I; Fuchs A; Deni I; Yeo T; Mok S; Fidock DA; Chalon S; Möhrle JJ; Parmar D; McCarthy JS; Kansagra K Lancet Infect Dis; 2022 Jun; 22(6):879-890. PubMed ID: 35247321 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects. Krause A; Dingemanse J; Mathis A; Marquart L; Möhrle JJ; McCarthy JS Br J Clin Pharmacol; 2016 Aug; 82(2):412-21. PubMed ID: 27062080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]